1. |
Cosnes J, Gower Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 2011, 140(6): 1785-1794.
|
2. |
Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology, 2017, 152(2): 313-321.
|
3. |
Aloi M, Di Nardo G, Romano G, et al. Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn’s disease: a prospective, blinded, comparison study. Gastrointest Endosc, 2015, 81(2): 420-427.
|
4. |
Solberg IC, Vatn MH, Høie O, et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol, 2007, 5(12): 1430-1438.
|
5. |
Gomollón F, Dignass A, Annese V, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: part 1: diagnosis and medical management. J Crohns Colitis, 2016, 11(1): 3-25.
|
6. |
Maconi G, Nylund K, Ripolles T, et al. EFSUMB recommendations and clinical guidelines for intestinal ultrasound (GIUS) in inflammatory bowel diseases. Ultraschall Med, 2018, 39(3): 304-317.
|
7. |
Lu C, Merrill C, Medellin A, et al. Bowel ultrasound state of the art: grayscale and doppler ultrasound, contrast enhancement, and elastography in crohn disease. J Ultrasound Med, 2019, 38(2): 271-288.
|
8. |
Fraquelli M, Colli A, Casazza G, et al. Role of US in detection of Crohn disease: meta-analysis. Radiology, 2005, 236(1): 95-101.
|
9. |
Nylund K, Maconi G, Hollerweger A, et al. EFSUMB recommendations and guidelines for gastrointestinal ultrasound. Ultraschall Med, 2017, 38(3): e1-e15.
|
10. |
Castiglione F, Mainenti PP, De Palma GD, et al. Noninvasive diagnosis of small bowel Crohn’s disease: direct comparison of bowel sonography and magnetic resonance enterography. Inflamm Bowel Dis, 2013, 19(5): 991-998.
|
11. |
Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis, 2013, 7(7): 556-585.
|
12. |
Colli A, Fraquelli M, Casazza G, et al. The architecture of diagnostic research: from bench to bedside--research guidelines using liver stiffness as an example. Hepatology, 2014, 60(1): 408-418.
|
13. |
Dong J, Wang H, Zhao J, et al. Ultrasound as a diagnostic tool in detecting active Crohn’s disease: a meta-analysis of prospective studies. Eur Radiol, 2014, 24(1): 26-33.
|
14. |
Parente F, Greco S, Molteni M, et al. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, X ray studies, and ileocolonoscopy. Gut, 2004, 53(11): 1652-1657.
|
15. |
Panés J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther, 2011, 34(2): 125-145.
|
16. |
Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology, 2008, 247(1): 64-79.
|
17. |
Maconi G, Bolzoni E, Giussani A, et al. Accuracy and cost of diagnostic strategies for patients with suspected Crohn’s disease. J Crohns Colitis, 2014, 8(12): 1684-1692.
|
18. |
Parente F, Greco S, Molteni M, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther, 2003, 18(10): 1009-1016.
|
19. |
Kucharzik T, Maaser C. Intestinal ultrasound and management of small bowel Crohn’s disease. Therap Adv Gastroenterol, 2018, 11: 1756284818771367.
|
20. |
Calabrese E, Zorzi F, Onali S, et al. Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn’s disease. Clin Gastroenterol Hepatol, 2013, 11(8): 950-955.
|
21. |
Gasche C, Moser G, Turetschek K, et al. Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease. Gut, 1999, 44(1): 112-117.
|
22. |
Maconi G, Bollani S, Bianchi PG. Ultrasonographic detection of intestinal complications in Crohn’s disease. Dig Dis Sci, 1996, 41(8): 1643-1648.
|
23. |
Parente F, Maconi G, Bollani S, et al. Bowel ultrasound in assessment of Crohn’s disease and detection of related small bowel strictures: a prospective comparative study versus X ray and intraoperative findings. Gut, 2002, 50(4): 490-495.
|
24. |
Biancone L, Calabrese E, Petruzziello C, et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn’s disease. Inflamm Bowel Dis, 2007, 13(10): 1256-1265.
|
25. |
Calabrese E, La Seta F, Buccellato A, et al. Crohn’s disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema. Inflamm Bowel Dis, 2005, 11(2): 139-145.
|
26. |
Thompson JS, Iyer KR, Dibaise JK, et al. Short bowel syndrome and Crohn’s disease. J Gastrointest Surg, 2003, 7(8): 1069-1072.
|
27. |
Kucharzik T, Wittig BM, Helwig U, et al. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clin Gastroenterol Hepatol, 2017, 15(4): 535-542.
|
28. |
Ripollés T, Paredes JM, Martinez-Pérez MJ, et al. Ultrasonographic changes at 12 weeks of Anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn’s disease: a multicenter study. Inflamm Bowel Dis, 2016, 22(10): 2465-2473.
|
29. |
Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: review of techniques and clinical applications. Theranostics, 2017, 7(5): 1303-1329.
|
30. |
Pecere S, Holleran G, Ainora ME, et al. Usefulness of contrast-enhanced ultrasound (CEUS) in inflammatory bowel disease (IBD). Dig Liver Dis, 2018, 50(8): 761-767.
|
31. |
Pita I, Magro F. Advanced imaging techniques for small bowel Crohn’s disease: what does the future hold?. Therap Adv Gastroenterol, 2018, 11: 1756283X18757185.
|
32. |
Pescatori LC, Mauri G, Savarino E, et al. Bowel sonoelastography in patients with Crohn’s disease: a systematic review. Ultrasound Med Biol, 2018, 44(2): 297-302.
|
33. |
Chen YJ, Mao R, Md XL, et al. Real-time shear wave ultrasound elastography differentiates fibrotic from inflammatory strictures in patients with Crohn’s disease. Inflamm Bowel Dis, 2018, 24(10): 2183-2190.
|
34. |
Lu C, Gui X, Chen W, et al. Ultrasound shear wave elastography and contrast enhancement: effective biomarkers in Crohn’s disease strictures. Inflamm Bowel Dis, 2017, 23(3): 421-430.
|
35. |
Serafin Z, Bialecki M, Bialecka A, et al. Contrast-enhanced ultrasound for detection of Crohn’s disease activity: systematic review and meta-analysis. J Crohns Colitis, 2016, 10(3): 354-362.
|
36. |
Migaleddu V, Quaia E, Scanu D, et al. Inflammatory activity in Crohn’s disease: CE-US. Abdom Imaging, 2011, 36(2): 142-148.
|
37. |
Medellin-Kowalewski A, Wilkens R, Wilson A, et al. Quantitative contrast-enhanced ultrasound parameters in Crohn disease: their role in disease activity determination with ultrasound. AJR Am J roentgenol, 2016, 206(1): 64-73.
|
38. |
Saevik F, Nylund K, Hausken T, et al. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn’s disease. Inflamm Bowel Dis, 2014, 20(11): 2029-2037.
|
39. |
Quaia E, Sozzi M, Angileri R, et al. Time-intensity curves obtained after microbubble injection can be used to differentiate responders from nonresponders among patients with clinically active crohn disease after 6 weeks of pharmacologic treatment. Radiology, 2016, 281(2): 606-616.
|
40. |
Ripollés T, Martínez-Pérez MJ, Paredes JM, et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn’s disease and other abdominal conditions. Eur J Radiol, 2013, 82(10): e525-e531.
|
41. |
Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med, 2012, 33(1): 33-59.
|
42. |
Ripollés T, Martinez MJ, Paredes JM, et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology, 2009, 253(1): 241-248.
|
43. |
Maconi G, Parente F, Bollani S, et al. Factors affecting splanchnic haemodynamics in Crohn’s disease: a prospective controlled study using Doppler ultrasound. Gut, 1998, 43(5): 645-650.
|
44. |
Medellin-Kowalewski A, Wilkens R, Wilson A, et al. Quantitative contrast-enhanced ultrasound parameters in Crohn disease: their role in disease activity determination with ultrasound. AJR Am J Roentgenol, 2016, 206(1): 64-73.
|
45. |
Esteban JM, Maldonado L, Sanchiz V, et al. Activity of Crohn’s disease assessed by colour Doppler ultrasound analysis of the affected loops. Eur Radiol, 2001, 11(8): 1423-1428.
|
46. |
Limberg B. Diagnosis of chronic inflammatory bowel disease by ultrasonography. Z Gastroenterol, 1999, 37(6): 495-508.
|
47. |
Rigazio C, Ercole E, Laudi C, et al. Abdominal bowel ultrasound can predict the risk of surgery in Crohn’s disease: proposal of an ultrasonographic score. Scand J Gastroenterol, 2009, 44(5): 585-593.
|
48. |
Calabrese E, Zorzi F, Zuzzi S, et al. Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn’s disease. J Crohns Colitis, 2012, 6(8): 852-860.
|
49. |
Novak KL, Kaplan GG, Panaccione R, et al. A simple ultrasound score for the accurate detection of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis, 2017, 23(11): 2001-2010.
|
50. |
Sturm A, Maaser C, Calabrese E, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis, 2018, 13(3): 273-284.
|